CN1233378C - Chinese medicine composition for treating oral cavity and throat diseases and its preparing method - Google Patents
Chinese medicine composition for treating oral cavity and throat diseases and its preparing method Download PDFInfo
- Publication number
- CN1233378C CN1233378C CN 03137148 CN03137148A CN1233378C CN 1233378 C CN1233378 C CN 1233378C CN 03137148 CN03137148 CN 03137148 CN 03137148 A CN03137148 A CN 03137148A CN 1233378 C CN1233378 C CN 1233378C
- Authority
- CN
- China
- Prior art keywords
- solution
- reference substance
- add
- adds
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title claims abstract description 52
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 238000000034 method Methods 0.000 title claims abstract description 34
- 201000010099 disease Diseases 0.000 title claims abstract description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 17
- 210000000214 mouth Anatomy 0.000 title claims abstract description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 75
- 238000002360 preparation method Methods 0.000 claims abstract description 21
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 20
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 18
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 claims abstract description 14
- 235000010339 sodium tetraborate Nutrition 0.000 claims abstract description 14
- 238000004821 distillation Methods 0.000 claims abstract description 13
- 229910021538 borax Inorganic materials 0.000 claims abstract description 12
- 239000004328 sodium tetraborate Substances 0.000 claims abstract description 12
- 238000003908 quality control method Methods 0.000 claims abstract description 11
- 241000207929 Scutellaria Species 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims description 144
- 238000012360 testing method Methods 0.000 claims description 105
- 239000000047 product Substances 0.000 claims description 73
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 72
- 239000013558 reference substance Substances 0.000 claims description 72
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 54
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 52
- 239000007921 spray Substances 0.000 claims description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 38
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 36
- 238000003756 stirring Methods 0.000 claims description 34
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 30
- 239000003208 petroleum Substances 0.000 claims description 30
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 24
- 239000012085 test solution Substances 0.000 claims description 24
- 229960004756 ethanol Drugs 0.000 claims description 22
- 239000007788 liquid Substances 0.000 claims description 22
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 claims description 18
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 18
- 239000007864 aqueous solution Substances 0.000 claims description 18
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 claims description 18
- 229960003321 baicalin Drugs 0.000 claims description 18
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 claims description 18
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 18
- 239000000741 silica gel Substances 0.000 claims description 18
- 229910002027 silica gel Inorganic materials 0.000 claims description 18
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 18
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 18
- 239000002904 solvent Substances 0.000 claims description 18
- 238000004809 thin layer chromatography Methods 0.000 claims description 18
- 239000000796 flavoring agent Substances 0.000 claims description 16
- 235000019634 flavors Nutrition 0.000 claims description 16
- 241000219109 Citrullus Species 0.000 claims description 13
- 241000628997 Flos Species 0.000 claims description 13
- 239000013078 crystal Substances 0.000 claims description 13
- 238000011282 treatment Methods 0.000 claims description 13
- 239000011230 binding agent Substances 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- DHRLEVQXOMLTIM-UHFFFAOYSA-N phosphoric acid;trioxomolybdenum Chemical compound O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.OP(O)(O)=O DHRLEVQXOMLTIM-UHFFFAOYSA-N 0.000 claims description 12
- 239000002244 precipitate Substances 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 9
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 8
- 229960000583 acetic acid Drugs 0.000 claims description 7
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 6
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 6
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 claims description 6
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 claims description 6
- 244000173166 Pyrus ussuriensis Species 0.000 claims description 6
- 235000011572 Pyrus ussuriensis Nutrition 0.000 claims description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- 238000012644 addition polymerization Methods 0.000 claims description 6
- 239000000853 adhesive Substances 0.000 claims description 6
- 230000001070 adhesive effect Effects 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 6
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 claims description 6
- 229910001626 barium chloride Inorganic materials 0.000 claims description 6
- ONBIUAZBGHXJDM-UHFFFAOYSA-J bismuth;potassium;tetraiodide Chemical compound [K+].[I-].[I-].[I-].[I-].[Bi+3] ONBIUAZBGHXJDM-UHFFFAOYSA-J 0.000 claims description 6
- 238000005660 chlorination reaction Methods 0.000 claims description 6
- 238000001514 detection method Methods 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 6
- 239000000945 filler Substances 0.000 claims description 6
- 239000012362 glacial acetic acid Substances 0.000 claims description 6
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 6
- 235000011477 liquorice Nutrition 0.000 claims description 6
- 239000006210 lotion Substances 0.000 claims description 6
- 229930014456 matrine Natural products 0.000 claims description 6
- JWHHANVGNNWIRI-UHFFFAOYSA-N methanol phosphoric acid hydrate Chemical compound O.OC.OP(O)(O)=O JWHHANVGNNWIRI-UHFFFAOYSA-N 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 6
- 238000004064 recycling Methods 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 239000000377 silicon dioxide Substances 0.000 claims description 6
- 239000001117 sulphuric acid Substances 0.000 claims description 6
- 235000011149 sulphuric acid Nutrition 0.000 claims description 6
- 238000011003 system suitability test Methods 0.000 claims description 6
- 238000001291 vacuum drying Methods 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 238000003556 assay Methods 0.000 claims description 5
- 208000011580 syndromic disease Diseases 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 229950008882 polysorbate Drugs 0.000 claims description 4
- 229920000136 polysorbate Polymers 0.000 claims description 4
- 238000012850 discrimination method Methods 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 3
- 241000202807 Glycyrrhiza Species 0.000 claims description 2
- 241000245240 Lonicera Species 0.000 claims description 2
- 241001180876 Saposhnikovia Species 0.000 claims description 2
- 239000006196 drop Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 238000004811 liquid chromatography Methods 0.000 claims 4
- 239000002994 raw material Substances 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000006870 function Effects 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 5
- 208000026435 phlegm Diseases 0.000 abstract description 5
- 241000700605 Viruses Species 0.000 abstract description 3
- 208000038016 acute inflammation Diseases 0.000 abstract description 2
- 230000036592 analgesia Effects 0.000 abstract description 2
- 230000036737 immune function Effects 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 abstract 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000596154 Belamcanda Species 0.000 abstract 1
- 244000241235 Citrullus lanatus Species 0.000 abstract 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 241000229179 Ledebouriella Species 0.000 abstract 1
- 229930195210 Ophiopogon Natural products 0.000 abstract 1
- 244000248557 Ophiopogon japonicus Species 0.000 abstract 1
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 241000293861 Scrophularia nodosa Species 0.000 abstract 1
- 241000123725 Sophora tonkinensis Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000006022 acute inflammation Effects 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 230000008030 elimination Effects 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 229940041616 menthol Drugs 0.000 abstract 1
- 210000003800 pharynx Anatomy 0.000 description 20
- 201000007100 Pharyngitis Diseases 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 6
- 206010068319 Oropharyngeal pain Diseases 0.000 description 5
- 208000016150 acute pharyngitis Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 230000003907 kidney function Effects 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 206010018910 Haemolysis Diseases 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 206010002953 Aphonia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010018286 Gingival pain Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
The present invention discloses a traditional Chinese medicament composition for curing the diseases of the oral cavity and the throat and a preparation method thereof. The medicament composition is mainly composed of watermelon frost, scutellaria, blackberrylily rhizome, vietnamese sophora roots, honeysuckle, ledebouriella roots, menthol, borneol, borax, figwort roots, ophiopogon roots and liquorice roots. When the traditional Chinese medicament composition is prepared, the methods of distillation, decoction and etanol extraction are adopted for the ingredients to fully perform the functions of the active ingredients of medicaments; and meanwhile, the present invention also provides a quality control method of discriminating the ingredients and measuring the contents for the composition. The composition preparation has better functions of acute inflammation resistance, fever relieving, analgesia, virus resistance, phlegm elimination, immune function enhancement and has no obvious side effect.
Description
Invention field
The present invention relates to a kind of Chinese medicine composition, particularly be used for the treatment of the Chinese medicine composition of oral cavity and throat diseases, relate to preparation method, purposes and the method for quality control of said composition simultaneously.
Background technology
Throat and oral cavity diseases belongs to traditional Chinese medical science categories such as " tonsillitis, sore throat, aphonia due to throat disease ", be subordinate to ability to speak, larynx section, diseases such as the said acute/chronic pharyngitis laryngitis of modern medicine, acute tonsillitis, oral ulcer, stomatitis, gingival swelling and pain, pathogeny Chinese medicine is thought " all diseases of throat all belong to fire ", mainly be body diseases caused by exogenous pathogenic factor pyretic toxicity and cause on the pathogenic fire scorchingly, or cause exopathogen because oral cavity and throat is unclean and invade.Moreover be exactly that plain body loses void, and cause hyperactivity of deficient fire.Modern medicine study thinks that the scorching card of oral cavity and throat disease mainly is an infected by microbes such as antibacterial, virus and causing, or body immunity is low, and antibacterial, virus are in the pathogenic microorganism growth imbalance of oral cavity and throat and cause infection.Also have due to the mechanical damage simultaneously, or excessively take place with throat.This disease can take place repeatedly.
The tradition Chinese medicine has much the commentary treatise of oral cavity throat disease, has also put down in writing many prescriptions, and as Yangyin Qingfei Tang, BINGPENG SAN etc., these prescriptions are to adopt according to concrete symptom, are the important component parts of Chinese medicine content.Ancient Chinese medicine medicine or Chinese medicine among the people are fully being summed up, excavating or utilized to the modern Chinese medicine theory also.Just introduce the many proved recipes of control oral cavity and throat diseases, typical prescription as Chinese medicine institution of higher learning teaching material " traditional Chinese medical science otolaryngology ", the control oral cavity and throat diseases is had directive function preferably.
According to the needs in market, according to traditional Chinese medicine theory, in conjunction with modern pharmaceutical science and technology, the present invention has released the sick Chinese medicine of a kind of treatment oral cavity and throat, and this curative effect of medication is definite, and is quality controllable, the no obvious toxic-side effects of safety, and preparation novelty, and it is convenient to use, and dosage is little.
Summary of the invention
One object of the present invention is to disclose a kind of Chinese medicine composition of new treatment oral cavity and throat diseases; Another object of the present invention is the method for the Chinese medicine composition of a kind of new treatment oral cavity and throat diseases of open preparation.The object of the invention also is to disclose a kind of method of quality control of new Chinese medicine composition.
The crude drug of pharmaceutical composition of the present invention is formed and proportioning following (by weight):
Watermelon crystal 20-60 weight portion Radix Scutellariae 75-220 weight portion Rhizoma Belamcandae 75-220 weight portion
Radix Sophorae Tonkinensis 50-150 weight portion Flos Lonicerae 80-240 weight portion Radix Saposhnikoviae 40-120 weight portion
Mentholum 1-4 weight portion Borneolum Syntheticum 1-4 weight portion Borax 10-50 weight portion
Radix Scrophulariae 40-120 weight portion 40-120 Radix Ophiopogonis weight portion Radix Glycyrrhizae 40-120 weight portion.
The optimum ratio of pharmaceutical composition crude drug of the present invention is:
Watermelon crystal 50 weight portion Radix Scutellariaes 80 weight portion Rhizoma Belamcandae 100 weight portions
Radix Sophorae Tonkinensis 95 weight portion Flos Loniceraes 120 weight portion Radix Saposhnikoviaes 65.5 weight portions
Mentholum 3.5 weight portion Borneolum Syntheticums 2.5 weight portion Boraxs 25 weight portions
Radix Scrophulariae 85 weight portion 62.5 weight portion Radix Glycyrrhizaes Radix Ophiopogonis 75 weight portions
Above Chinese medicine composition can add adjuvant and make any dosage form on the pharmaceutics meaning, contains spray, tablet, capsule, syrup, granule, drop pill, pill, paster etc., preferred spray.
The present composition can add following adjuvant and make spray:
Steviosin 1-5 weight portion Polysorbate 15-90 parts by volume 95% ethanol 6-25 parts by volume.
The method that the present composition prepares spray is:
The above present composition 12 flavors, Flos Lonicerae, Radix Saposhnikoviae two flavors add the water distillation, collect the about 180-220 parts by volume of distillate, and the aqueous solution after the distillation filters, and device is preserved in addition; 6 flavors such as medicinal residues and Radix Scutellariae, Rhizoma Belamcandae, Radix Sophorae Tonkinensis, Radix Scrophulariae, Radix Ophiopogonis, Radix Glycyrrhizae decoct with water three times, each 0.5-3 hour, collecting decoction filtered, filtrate and above-mentioned aqueous solution merge, being concentrated into relative density is 1.05-1.40 (is under 40-90 ℃ in temperature), adds 40-95% ethanol and makes and contain alcohol and reach 40-80%, fully stirs, left standstill 12-36 hour, get supernatant and filter, filtrate recycling ethanol, being concentrated into relative density is the clear paste of 1.05-1.40 (is under 40-90 ℃ in temperature); Mentholum, Borneolum Syntheticum add an amount of 70-95% dissolve with ethanol, after addition polymerization Pyrusussuriensis ester stirs evenly again, slowly add in the above-mentioned distillate, and the limit edged stirs, and adds above-mentioned clear paste again and stirs evenly; Watermelon crystal, Borax add an amount of hot water dissolving, filter; Steviosin adds an amount of hot water dissolving, is chilled to room temperature, adds in the above-mentioned medicinal liquid, adds water to 1000 parts by volume, stirs evenly, and filters, and fill promptly gets spray.
Above institute weight portion/state volume is corresponding with g/ml.
The method of quality control that the present composition is made spray comprises discriminating and/or assay.
Discrimination method comprises a kind of and/or several in the following method:
A. get this product 2ml, add barium chloride test solution 1ml, promptly generate white precipitate; Separate, be deposited in the hydrochloric acid and do not dissolve;
B. get this product 10ml, put in the water-bath and steam to thick, add sulphuric acid 2ml, after the mixing, add methanol 8ml, ignition promptly generates the boundary zone green flame;
C. get this product 10ml, add petroleum ether (20～70 ℃) 20ml, jolting is extracted gently, leaves standstill, and gets supernatant, volatilizes, and residue adds dehydrated alcohol 1ml makes dissolving, as need testing solution; Other gets Borneolum Syntheticum, Mentholum reference substance, adds dehydrated alcohol respectively and makes the solution that every 1ml contains 2mg, in contrast product solution; Test according to thin layer chromatography (appendix VIB of Chinese Pharmacopoeia version in 2000), draw each 2 μ l of above-mentioned three kinds of solution, put respectively in same be on the silica gel g thin-layer plate of adhesive with the sodium carboxymethyl cellulose, petroleum ether (20～70 ℃)-ethyl acetate-benzene that with the ratio is 7-10: 1-2: 1-3 is developing solvent, launch, take out, dry, spray is with the phosphomolybdic acid test solution, and it is clear to be heated to the speckle colour developing under 105 ℃; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the speckle of same color;
D. get this product 10ml, add strong ammonia solution 0.3ml, extract 1-3 time with the chloroform jolting, each 10ml, combined chloroform liquid, evaporate to dryness, residue add chloroform 1ml makes dissolving, as need testing solution; Other gets the matrine reference substance, and chlorination is copied into the solution that every 1ml contains 1mg, in contrast product solution; Test according to thin layer chromatography (an appendix VI of Chinese Pharmacopoeia version in 2000 B), draw need testing solution 2 μ l, reference substance solution 5 μ l, put respectively in same be on the silica gel g thin-layer plate of binding agent with the sodium carboxymethyl cellulose, ethyl acetate-methanol-the strong ammonia solution that with the ratio is 9-12: 0.8-1.5: 0.1-0.4 is developing solvent, launches, and takes out, dry, spray is with rare bismuth potassium iodide test solution; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the speckle of same color;
E. get this product 30ml, extract 1-3 time with petroleum ether (50～90 ℃) jolting, each 15ml discards petroleum ether liquid, aqueous solution stirs with 2mol/L hydrochloric acid solution adjust pH to 2, and is centrifugal, filters, taking precipitate, oven dry grinds, and adds chloroform 30ml, hydrochloric acid 3ml, reflux 1-2 hour, put coldly, filter, divide and get chloroform solution, water 10ml washing discards water lotion, and chloroform solution adds anhydrous sodium sulfate and dewaters in right amount, evaporate to dryness, residue add dehydrated alcohol 1ml makes dissolving, as need testing solution; Extracting liquorice subacid reference substance adds dehydrated alcohol and makes the solution that every 1ml contains 2mg, in contrast product solution in addition; Test according to thin layer chromatography (an appendix VI of Chinese Pharmacopoeia version in 2000 B), draw need testing solution 3～5 μ l, reference substance solution 3 μ l, put respectively in same be on the silica gel g thin-layer plate of binding agent with the sodium carboxymethyl cellulose, be that petroleum ether (30～60 ℃)-benzene-ethyl acetate-glacial acetic acid of 9-12: 18-25: 8-12: 0.3-0.7 is developing solvent with the ratio, launch, take out, dry, spray is with the phosphomolybdic acid test solution, and it is clear to be heated to speckle colour developing under 105-115 ℃; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the speckle of same color;
Assay: measure according to high performance liquid chromatography (an appendix VI of Chinese Pharmacopoeia version in 2000 D), chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; With ratio is that the methanol-water-phosphoric acid of 45-55: 45-55: 0.1-0.4 is a mobile phase; The detection wavelength is 277nm; Theoretical cam curve is calculated by the baicalin peak should be not less than 3500; It is an amount of that the preparation of reference substance solution, precision take by weighing under 50-70 ℃ of temperature vacuum drying 3-5 hour baicalin reference substance, adds methanol and make the solution that every 1ml contains 60 μ g, promptly gets reference substance solution; This product 0.5ml is measured in the preparation of need testing solution, precision, puts in the 50ml measuring bottle, adds 45-60% methanol and is diluted to scale, shakes up, and filters, and promptly gets need testing solution; Algoscopy, accurate respectively reference substance solution and each 10 μ l of need testing solution of drawing inject chromatograph of liquid, measure, that is and: the every 1ml of this product contains Radix Scutellariae with baicalin (C
21H
18O
11) meter, must not be less than 5.8-6.6mg.
Present composition preparation has good anti-acute inflammation, analgesic, analgesia, antibiotic, antiviral, eliminate the phlegm and raise immunity effect and having no side effect.
The result of following experimental example can further specify the present invention.
Experimental example 1Present composition preparation (white a kind of reed mentioned in ancient books pharynx nebula for treating) pharmacodynamics test
1, by mice ear method, the evidence of mice acetic acid peritonitis method, this product can obviously suppress mice auricle swelling and the mice capillary permeability increases, and illustrates that this product has good antiinflammatory action.
2, this product has significant refrigeration function to heating due to the rat skin lower injection yeast.
3, the mouse writhing method test shows that this product has significant analgesic activity.
4, this product has good anti-golden yellow Portugal fungus ball bacterium, escherichia coli, Cray uncle pneumobacillus, streptococcus pneumoniae, beta hemolysis type streptococcus, alpha streptococcus, and the effect of adenovirus through in vitro tests proof.The mice in vivo test proves to have pharmacological actions such as anti-beta hemolysis type streptococcus, influenza virus.
5, this product has the macrophage phagocytic of enhancing ability to the mice of the immunologic hypofunction of caused by cyclophosphamide, increases immune organ weight such as thymus and spleen, strengthens the effect of humoral immune function.
6, can increase the phenol red bronchus excretion of mice amount, illustrate to have obvious phlegm-dispelling functions.
Experimental example 2Toxicity test
Acute toxicity test:
1, acute toxicity test: the mice maximum tolerated dose is 120g/kg, is with daily dose 1200 times of clinical plan.
2, skin anaphylactic test: this product does not have sensitivity response to guinea pig skin.
3, mucomembranous pungency test: this product is to oral cavity, throat and tunica mucosa tracheae nonirritant.
Long term toxicity test:
Rat is retained animal and continues to observe for two weeks with this product 6g/kg (clinical plan is with 60 times of daily dose) gastric infusion 30 days continuously, there is no the toxicity that outward appearance, body weight gain, hematological indices, hepatic and renal function and organs and tissues appear in animal and changes.Point out this medicine life-time service toxicity little, safety coefficient is big.Retain animal and continue to observe for two weeks, above-mentioned every index toxicity also do not occur and changes.
Result of the test shows that this product is safe with the dosage and the course of treatment in clinical practice by plan.
Experimental example 3Clinical experiment
II clinical trial phase: according to the requirement of national relevant laws and regulations and technology, according to Ministry of Public Health clinical trial method, adopt parallel control, demixing zone group at random, the method for double blinding dual analog, multiple center trial, observe this product and treat wind-heat syndrome of acute pharyngitis clinical efficacy, toxic and side effects and untoward reaction, its effectiveness and safety are made evaluation.200 routine patients are observed in this test altogether, and wherein, test group is 100 examples, and matched group is 100 examples.Two groups of patient's background informations and clinical physical data have comparability (only there were significant differences between the average year age group).Clinical test results shows: the clinical recovery rate of this spray treatment wind-heat syndrome of acute pharyngitis is 52%, and obvious effective rate is 26%, and total effective rate is 78%, and matched group is respectively 51%, 23%, 74%; This product has no side effect substantially, and the heart, liver, renal function, blood system no abnormality seen are changed.
The III clinical trial phase: according to the requirement of national relevant laws and regulations and technology, according to Ministry of Public Health clinical trial method, adopt parallel control, demixing zone group at random, the method for multiple center trial, estimate the effectiveness and the safety of this product treatment wind-heat syndrome of acute pharyngitis.471 routine patients are observed in this test altogether, and wherein, test group is 356 examples, and matched group is 115 examples.Clinical test results shows: test group to pharyngalgia, dry pharynx is scorching hot and pharyngeal mucous membrane, the outstanding bullate improvement of Yong Hong significantly are better than matched group.Positive symptom sign disappearance rate relatively aspect, test group pharyngalgia, dry pharynx are scorching hot, the 6th day disappearance rate of pharyngeal mucous membrane congestion and edema and pharynx rear wall lymph follicle significantly is better than matched group.Primary symptom integration and total mark all significantly descend after two groups of treatments.The drop-out value test group of treatment back primary symptom integration and total mark significantly is better than matched group.Meet scheme collection test group cure rate 42.13%, obvious effective rate 29.78%, total effective rate 71.91%, matched group is respectively 23.48%, 31.30%, and 54.78%.Comprehensive therapeutic effect, cure rate and the total effective rate of test group treatment wind-heat syndrome of acute pharyngitis all significantly are better than matched group; Trial drug is not observed in this test has anomalous effects to the heart, liver, renal function, blood system.
Following embodiment all can realize the effect of above-mentioned experimental example.
Embodiment 1Spray
Watermelon crystal 30g Radix Scutellariae 100g Rhizoma Belamcandae 80g Radix Sophorae Tonkinensis I00g
Flos Lonicerae 150g Radix Saposhnikoviae 70g Mentholum 2g Borneolum Syntheticum 1.5g
Borax 20g Radix Scrophulariae 85g 69.5g Radix Ophiopogonis Radix Glycyrrhizae 55g
Adjuvant:
Steviosin 3.5g Polysorbate 30ml 95% ethanol 20ml
More than 12 flavors, Flos Lonicerae, Radix Saposhnikoviae two flavors add the water distillation, collect the about 190ml of distillate, the aqueous solution after the distillation filters, device preservation in addition; 6 flavors such as medicinal residues and Radix Scutellariae, Rhizoma Belamcandae, Radix Sophorae Tonkinensis, Radix Scrophulariae, Radix Ophiopogonis, Radix Glycyrrhizae decoct with water three times, each 2 hours, collecting decoction filtered, filtrate and above-mentioned aqueous solution merge, being concentrated into 80 ℃ of relative densities is 1.25, adds 70% ethanol and makes and contain alcohol and reach 78%, fully stirs, left standstill 15 hours, get supernatant and filter, filtrate recycling ethanol is concentrated into 75 ℃ of relative densities and is 1.26 clear paste.Mentholum, Borneolum Syntheticum add an amount of 78% dissolve with ethanol, after addition polymerization Pyrusussuriensis ester 85ml stirs evenly again, slowly add in the above-mentioned distillate, and the limit edged stirs, and adds above-mentioned clear paste again and stirs evenly.Watermelon crystal, Borax add an amount of hot water dissolving, filter; Steviosin adds an amount of hot water dissolving, is chilled to room temperature, adds in the above-mentioned medicinal liquid, adds water to 1000ml, stirs evenly, filter, and fill, promptly.Function is in curing mainly: have heat-clearing and toxic substances removing, dispelling wind reduces phlegm, and the function of detumescence sore-throat relieving is used for exuberant lung-stomach heat, and wind heat is violated the pharyngalgia sore throat due to the table.Usage and dosage: be sprayed on the affected part, press for one time 5,12 times on the one
Embodiment 2Tablet
Watermelon crystal 40g Radix Scutellariae 200g Rhizoma Belamcandae 180g Radix Sophorae Tonkinensis 130g
Flos Lonicerae 200g Radix Saposhnikoviae 100g Mentholum 3g Borneolum Syntheticum 3g
Borax 40g Radix Scrophulariae 100g 100g Radix Ophiopogonis Radix Glycyrrhizae 100g
More than 12 flavors, Flos Lonicerae, Radix Saposhnikoviae two flavors add the water distillation, collect the about 200ml of distillate, the aqueous solution after the distillation filters, device preservation in addition; 6 flavors such as medicinal residues and Radix Scutellariae, Rhizoma Belamcandae, Radix Sophorae Tonkinensis, Radix Scrophulariae, Radix Ophiopogonis, Radix Glycyrrhizae decoct with water three times, each 2 hours, collecting decoction filtered, filtrate and above-mentioned aqueous solution merge, being concentrated into 70 ℃ of relative densities is 1.20, adds 60% ethanol and makes and contain alcohol and reach 70%, fully stirs, left standstill 26 hours, get supernatant and filter, filtrate recycling ethanol is concentrated into 70 ℃ of relative densities and is 1.20 clear paste.Mentholum, Borneolum Syntheticum add an amount of 80% dissolve with ethanol, after addition polymerization Pyrusussuriensis ester 85ml stirs evenly again, slowly add in the above-mentioned distillate, and the limit edged stirs, and adds above-mentioned clear paste again and stirs evenly.Watermelon crystal, Borax add an amount of hot water dissolving, filter; Make tablet through conventional technology.Function is in curing mainly: have heat-clearing and toxic substances removing, dispelling wind reduces phlegm, and the function of detumescence sore-throat relieving is used for exuberant lung-stomach heat, and wind heat is violated the pharyngalgia sore throat due to the table.Usage and dosage: oral, a 2-5 sheet, 3 times on the one.
Embodiment 3Capsule
Watermelon crystal 30g Radix Scutellariae 150g Rhizoma Belamcandae 130g Radix Sophorae Tonkinensis 80g
Flos Lonicerae 150g Radix Saposhnikoviae 60g Mentholum 3g Borneolum Syntheticum 3g
Borax 30g Radix Scrophulariae 60g 80g Radix Ophiopogonis Radix Glycyrrhizae 80g
More than 12 flavors, Flos Lonicerae, Radix Saposhnikoviae two flavors add the water distillation, collect the about 200ml of distillate, the aqueous solution after the distillation filters, device preservation in addition; 6 flavors such as medicinal residues and Radix Scutellariae, Rhizoma Belamcandae, Radix Sophorae Tonkinensis, Radix Scrophulariae, Radix Ophiopogonis, Radix Glycyrrhizae decoct with water three times, each 2 hours, collecting decoction filtered, filtrate and above-mentioned aqueous solution merge, being concentrated into 70 ℃ of relative densities is 1.20, adds 60% ethanol and makes and contain alcohol and reach 70%, fully stirs, left standstill 26 hours, get supernatant and filter, filtrate recycling ethanol is concentrated into 70 ℃ of relative densities and is 1.20 clear paste.Mentholum, Borneolum Syntheticum add an amount of 80% dissolve with ethanol, after addition polymerization Pyrusussuriensis ester 85ml stirs evenly again, slowly add in the above-mentioned distillate, and the limit edged stirs, and adds above-mentioned clear paste again and stirs evenly.Watermelon crystal, Borax add an amount of hot water dissolving, filter; Make capsule through conventional technology.
Embodiment 4The method of quality control of spray of the present invention
Differentiate: A. gets this product 2ml, adds barium chloride test solution 1ml, promptly generates white precipitate; Separate, be deposited in the hydrochloric acid and do not dissolve;
B. get this product 10ml, put in the water-bath and steam to thick, add sulphuric acid 2ml, after the mixing, add methanol 8ml, ignition promptly generates the boundary zone green flame;
C. get this product 10ml, add petroleum ether (30～60 ℃) 20ml, jolting is extracted gently, leaves standstill, and gets supernatant, volatilizes, and residue adds dehydrated alcohol 1ml makes dissolving, as need testing solution; Other gets Borneolum Syntheticum, Mentholum reference substance, adds dehydrated alcohol respectively and makes the solution that every 1ml contains 2mg, in contrast product solution; Test according to thin layer chromatography (appendix VIB of Chinese Pharmacopoeia version in 2000), draw each 2 μ l of above-mentioned three kinds of solution, put respectively in same be on the silica gel g thin-layer plate of adhesive with the sodium carboxymethyl cellulose, with ratio is that 9: 1: 2 petroleum ether (30～60 ℃)-ethyl acetate-benzene is developing solvent, launch, take out, dry, spray is with the phosphomolybdic acid test solution, and it is clear to be heated to the speckle colour developing at 105 ℃; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the speckle of same color;
D. get this product 10ml, add strong ammonia solution 0.3ml, extract 2 times with the chloroform jolting, each 10ml, combined chloroform liquid, evaporate to dryness, residue add chloroform 1ml makes dissolving, as need testing solution; Other gets the matrine reference substance, and chlorination is copied into the solution that every 1ml contains 1mg, in contrast product solution; Test according to thin layer chromatography (an appendix VI of Chinese Pharmacopoeia version in 2000 B), draw need testing solution 2 μ l, reference substance solution 5 μ l, put respectively in same be on the silica gel g thin-layer plate of binding agent with the sodium carboxymethyl cellulose, with ratio is that ethyl acetate-methanol-strong ammonia solution of 10: 1: 0.2 is developing solvent, launches, and takes out, dry, spray is with rare bismuth potassium iodide test solution; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the speckle of same color;
E. get this product 30ml, extract 2 times with petroleum ether (60～90 ℃) jolting, each 15ml discards petroleum ether liquid, aqueous solution stirs with 2mol/L hydrochloric acid solution adjust pH to 2, and is centrifugal, filters, taking precipitate, oven dry grinds, and adds chloroform 30ml, hydrochloric acid 3ml, reflux 1 hour is put coldly, filters, divide and get chloroform solution, water 10ml washing discards water lotion, and chloroform solution adds anhydrous sodium sulfate and dewaters in right amount, evaporate to dryness, residue add dehydrated alcohol 1ml makes dissolving, as need testing solution; Extracting liquorice subacid reference substance adds dehydrated alcohol and makes the solution that every 1ml contains 2mg, in contrast product solution in addition; Test according to thin layer chromatography (an appendix VI of Chinese Pharmacopoeia version in 2000 B), draw need testing solution 3～5 μ l, reference substance solution 3 μ l, put respectively in same be on the silica gel g thin-layer plate of binding agent with the sodium carboxymethyl cellulose, be 10: 20: 10 with ratio: 0.5 petroleum ether (30～60 ℃)-benzene-ethyl acetate-glacial acetic acid is developing solvent, launches, take out, dry, spray is with the phosphomolybdic acid test solution, and it is clear to be heated to speckle colour developing at 105 ℃; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the speckle of same color;
Assay: measure according to high performance liquid chromatography (an appendix VI of Chinese Pharmacopoeia version in 2000 D), chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; With ratio is that 50: 50: 0.2 methanol-water-phosphoric acid is a mobile phase; The detection wavelength is 277nm; Theoretical cam curve is calculated by the baicalin peak should be not less than 3500; The preparation of reference substance solution, precision take by weighing at 4 hours baicalin reference substance of 60 ℃ of vacuum dryings an amount of, add methanol and make the solution that every 1ml contains 60 μ g, promptly get reference substance solution; This product 0.5ml is measured in the preparation of need testing solution, precision, puts in the 50ml measuring bottle, adds 50% methanol and is diluted to scale, shakes up, and filters, and promptly gets need testing solution; Algoscopy, accurate respectively reference substance solution and each 10 μ l of need testing solution of drawing inject chromatograph of liquid, measure, that is and: the every 1ml of this product contains Radix Scutellariae with baicalin (C
21H
18O
11) meter, must not be less than 5.8mg.
Claims (15)
1, a kind of Chinese medicine composition for the treatment of oral cavity and throat diseases is characterized in that this Chinese medicine composition made by following raw material medicaments:
Watermelon crystal 20-60 weight portion Radix Scutellariae 75-220 weight portion Rhizoma Belamcandae 75-220 weight portion
Radix Sophorae Tonkinensis 50-150 weight portion Flos Lonicerae 80-240 weight portion Radix Saposhnikoviae 40-120 weight portion
Mentholum 1-4 weight portion Borneolum Syntheticum 1-4 weight portion Borax 10-50 weight portion
Radix Scrophulariae 40-120 weight portion 40-120 Radix Ophiopogonis weight portion Radix Glycyrrhizae 40-120 weight portion.
2, Chinese medicine composition as claimed in claim 1 is characterized in that this Chinese medicine composition made by following raw material medicaments:
Watermelon crystal 50 weight portion Radix Scutellariaes 80 weight portion Rhizoma Belamcandae 100 weight portions
Radix Sophorae Tonkinensis 95 weight portion Flos Loniceraes 120 weight portion Radix Saposhnikoviaes 65.5 weight portions
Mentholum 3.5 weight portion Borneolum Syntheticums 2.5 weight portion Boraxs 25 weight portions
Radix Scrophulariae 85 weight portion 62.5 weight portion Radix Glycyrrhizaes Radix Ophiopogonis 75 weight portions.
3, Chinese medicine composition as claimed in claim 1 or 2 is characterized in that this Chinese medicine composition adds adjuvant and makes any dosage form on the pharmaceutics meaning.
4, Chinese medicine composition as claimed in claim 3 is characterized in that described dosage form is spray, tablet, capsule, syrup, granule, drop pill, pill or paster agent.
5,, it is characterized in that this Chinese medicine composition adds adjuvant steviosin 1-5 weight portion, Polysorbate 15-90 parts by volume and 95% ethanol 6-25 parts by volume and makes spray as claim 3 or 4 described Chinese medicine compositions.
6, Chinese medicine composition as claimed in claim 5 is characterized in that this Chinese medicine composition adds adjuvant steviosin 4 weight portions, Polysorbate 30 parts by volume and 95% ethanol, 12 parts by volume and makes spray.
7, as claim 5 or 6 described Chinese medicine composition spray preparing process, it is characterized in that this method is: Flos Lonicerae, Radix Saposhnikoviae two flavors add the water distillation, collect distillate 180-220 parts by volume, and the aqueous solution after the distillation filters, and device is preserved in addition; Medicinal residues and Radix Scutellariae, Rhizoma Belamcandae, Radix Sophorae Tonkinensis, Radix Scrophulariae, Radix Ophiopogonis, Radix Glycyrrhizae 6 flavors decoct with water three times, and each 0.5-3 hour, collecting decoction, filter, filtrate and above-mentioned aqueous solution merge, and being concentrated into 40-90 ℃ of relative density is 1.05-1.40, add 40-95% ethanol and make and contain alcohol and reach 40-80%, fully stir, left standstill 12-36 hour, and got supernatant and filter filtrate recycling ethanol, be concentrated into the extractum that relative density is 1.05-1.40, temperature is 40-90 ℃; Mentholum, Borneolum Syntheticum add an amount of 70-95% dissolve with ethanol, after addition polymerization Pyrusussuriensis ester stirs evenly again, slowly add in the above-mentioned distillate, and the limit edged stirs, and adds above-mentioned clear paste again and stirs evenly; Watermelon crystal, Borax add an amount of hot water dissolving, filter; Steviosin adds an amount of hot water dissolving, is chilled to room temperature, adds in the above-mentioned medicinal liquid, adds water to 1000 parts by volume, stirs evenly, and filters, and fill promptly gets spray.
8, Chinese medicine composition spray preparing process as claimed in claim 7 is characterized in that this method is: Flos Lonicerae, Radix Saposhnikoviae two flavors add the water distillation, collect distillate 190 parts by volume, and the aqueous solution after the distillation filters, and device is preserved in addition; Medicinal residues and Radix Scutellariae, Rhizoma Belamcandae, Radix Sophorae Tonkinensis, Radix Scrophulariae, Radix Ophiopogonis, Radix Glycyrrhizae 6 flavors decoct with water three times, each 2 hours, collecting decoction filtered, filtrate and above-mentioned aqueous solution merge, being concentrated into 80 ℃ of relative densities is 1.25, adds 70% ethanol and makes and contain alcohol and reach 78%, fully stirs, left standstill 15 hours, get supernatant and filter, filtrate recycling ethanol is concentrated into 75 ℃ of relative densities and is 1.26 clear paste; Mentholum, Borneolum Syntheticum add an amount of 78% dissolve with ethanol, after addition polymerization Pyrusussuriensis ester stirs evenly again, slowly add in the above-mentioned distillate, and the limit edged stirs, and adds above-mentioned clear paste again and stirs evenly; Watermelon crystal, Borax add an amount of hot water dissolving, filter; Steviosin adds an amount of hot water dissolving, is chilled to room temperature, adds in the above-mentioned medicinal liquid, adds water to 1000 parts by volume, stirs evenly, and filters, and fill promptly gets spray.
9,, it is characterized in that discrimination method in this method comprises one or more in the following discriminating as the method for quality control of arbitrary described Chinese medicine composition composition spray among the claim 3-6:
A. get this product 2ml, add barium chloride test solution 1ml, promptly generate white precipitate; Separate, be deposited in the hydrochloric acid and do not dissolve;
B. get this product 10ml, put in the water-bath and steam to thick, add sulphuric acid 2ml, after the mixing, add methanol 8ml, ignition promptly generates the boundary zone green flame;
C. get this product 10ml, add 20～70 ℃ of petroleum ether 20ml, jolting is extracted gently, leaves standstill, and gets supernatant, volatilizes, and residue adds dehydrated alcohol 1ml makes dissolving, as need testing solution; Other gets Borneolum Syntheticum, Mentholum reference substance, adds dehydrated alcohol respectively and makes the solution that every 1ml contains 2mg, in contrast product solution; Test according to thin layer chromatography, draw each 2 μ l of above-mentioned three kinds of solution, put respectively in same be on the silica gel g thin-layer plate of adhesive with the sodium carboxymethyl cellulose, 20～70 ℃-ethyl acetate-benzene of petroleum ether that with the ratio is 7-10: 1-2: 1-3 is developing solvent, launch, take out, dry, spray is with the phosphomolybdic acid test solution, and it is clear to be heated to the speckle colour developing at 105 ℃; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the speckle of same color;
D. get this product 10ml, add strong ammonia solution 0.3ml, extract 1-3 time with the chloroform jolting, each 10ml, combined chloroform liquid, evaporate to dryness, residue add chloroform 1ml makes dissolving, as need testing solution; Other gets the matrine reference substance, and chlorination is copied into the solution that every 1ml contains 1mg, in contrast product solution; Test according to thin layer chromatography, draw need testing solution 2 μ l, reference substance solution 5 μ l, put respectively in same be on the silica gel g thin-layer plate of binding agent with the sodium carboxymethyl cellulose, ethyl acetate-methanol-the strong ammonia solution that with the ratio is 9-12: 0.8-1.5: 0.1-0.4 is developing solvent, launches, and takes out, dry, spray is with rare bismuth potassium iodide test solution; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the speckle of same color;
E. get this product 30ml, extract 1-3 time with 50～90 ℃ of petroleum ether joltings, each 15ml discards petroleum ether liquid, aqueous solution stirs with 2mol/L hydrochloric acid solution adjust pH to 2, and is centrifugal, filters, taking precipitate, oven dry grinds, and adds chloroform 30ml, hydrochloric acid 3ml, reflux 1-2 hour, put coldly, filter, divide and get chloroform solution, water 10ml washing discards water lotion, and chloroform solution adds anhydrous sodium sulfate and dewaters in right amount, evaporate to dryness, residue add dehydrated alcohol 1ml makes dissolving, as need testing solution; Extracting liquorice subacid reference substance adds dehydrated alcohol and makes the solution that every 1ml contains 2mg, in contrast product solution in addition; Test according to thin layer chromatography, draw need testing solution 3～5 μ l, reference substance solution 3 μ l, put respectively in same be on the silica gel g thin-layer plate of binding agent with the sodium carboxymethyl cellulose, be that 30～60 ℃-benzene-ethyl acetate of petroleum ether-glacial acetic acid of 9-12: 18-25: 8-12: 0.3-0.7 is developing solvent with the ratio, launch, take out, dry, spray is with the phosphomolybdic acid test solution, and it is clear to be heated to speckle colour developing at 105-115 ℃; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the speckle of same color.
10, the method for quality control of Chinese medicine composition composition spray as claimed in claim 9 is characterized in that discrimination method in this method comprises one or more in the following discriminating:
A. get this product 2ml, add barium chloride test solution 1ml, promptly generate white precipitate; Separate, be deposited in the hydrochloric acid and do not dissolve;
B. get this product 10ml, put in the water-bath and steam to thick, add sulphuric acid 2ml, after the mixing, add methanol 8ml, ignition promptly generates the boundary zone green flame;
C. get this product 10ml, add 30～60 ℃ of petroleum ether 20ml, jolting is extracted gently, leaves standstill, and gets supernatant, volatilizes, and residue adds dehydrated alcohol 1ml makes dissolving, as need testing solution; Other gets Borneolum Syntheticum, Mentholum reference substance, adds dehydrated alcohol respectively and makes the solution that every 1ml contains 2mg, in contrast product solution; Test according to thin layer chromatography, draw each 2 μ l of above-mentioned three kinds of solution, put respectively in same be on the silica gel g thin-layer plate of adhesive with the sodium carboxymethyl cellulose, with ratio is that 30～60 ℃-ethyl acetate-benzene of petroleum ether of 9: 1: 2 is developing solvent, launch, take out, dry, spray is with the phosphomolybdic acid test solution, and it is clear to be heated to the speckle colour developing at 105 ℃; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the speckle of same color;
D. get this product 10ml, add strong ammonia solution 0.3ml, extract 2 times with the chloroform jolting, each 10ml, combined chloroform liquid, evaporate to dryness, residue add chloroform 1ml makes dissolving, as need testing solution; Other gets the matrine reference substance, and chlorination is copied into the solution that every 1ml contains 1mg, in contrast product solution; Test according to thin layer chromatography, draw need testing solution 2 μ l, reference substance solution 5 μ l, put respectively in same be on the silica gel g thin-layer plate of binding agent with the sodium carboxymethyl cellulose, with ratio is that ethyl acetate-methanol-strong ammonia solution of 10: 1: 0.2 is developing solvent, launches, and takes out, dry, spray is with rare bismuth potassium iodide test solution; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the speckle of same color;
E. get this product 30ml, extract 2 times with 60～90 ℃ of petroleum ether joltings, each 15ml discards petroleum ether liquid, aqueous solution stirs with 2mol/L hydrochloric acid solution adjust pH to 2, and is centrifugal, filters, taking precipitate, oven dry grinds, and adds chloroform 30ml, hydrochloric acid 3ml, reflux 1 hour is put coldly, filters, divide and get chloroform solution, water 10ml washing discards water lotion, and chloroform solution adds anhydrous sodium sulfate and dewaters in right amount, evaporate to dryness, residue add dehydrated alcohol 1ml makes dissolving, as need testing solution; Extracting liquorice subacid reference substance adds dehydrated alcohol and makes the solution that every 1ml contains 2mg, in contrast product solution in addition; Test according to thin layer chromatography, draw need testing solution 3～5 μ l, reference substance solution 3 μ l, put respectively in same be on the silica gel g thin-layer plate of binding agent with the sodium carboxymethyl cellulose, be 10: 20: 10 with ratio: 30～60 ℃-benzene-ethyl acetate of petroleum ether-glacial acetic acid of 0.5 is developing solvent, launches, take out, dry, spray is with the phosphomolybdic acid test solution, and it is clear to be heated to speckle colour developing at 105 ℃; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the speckle of same color.
11, as the method for quality control of arbitrary described Chinese medicine composition composition spray among the claim 3-6, it is characterized in that the content assaying method in this method is: according to high effective liquid chromatography for measuring, chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; With ratio is that the methanol-water-phosphoric acid of 45-55: 45-55: 0.1-0.4 is a mobile phase; The detection wavelength is 277nm; Theoretical cam curve is calculated by the baicalin peak should be not less than 3500; The preparation of reference substance solution, precision take by weighing at 50-70 ℃ of vacuum drying 3-5 hour baicalin reference substance an amount of, add methanol and make the solution that every 1ml contains 60 μ g, promptly get reference substance solution; This product 0.5ml is measured in the preparation of need testing solution, precision, puts in the 50ml measuring bottle, adds 45-60% methanol and is diluted to scale, shakes up, and filters, and promptly gets need testing solution; Algoscopy, accurate respectively reference substance solution and each 10 μ l of need testing solution of drawing inject chromatograph of liquid, measure, that is and: the every 1ml of this product contains Radix Scutellariae in baicalin, must not be less than 5.8-6.6mg.
12, the method for quality control of Chinese medicine composition composition spray as claimed in claim 11, it is characterized in that the content assaying method in this method is: according to high effective liquid chromatography for measuring, chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; With ratio is that 50: 50: 0.2 methanol-water-phosphoric acid is a mobile phase; The detection wavelength is 277nm; Theoretical cam curve is calculated by the baicalin peak should be not less than 3500; The preparation of reference substance solution, precision take by weighing at 4 hours baicalin reference substance of 60 ℃ of vacuum dryings an amount of, add methanol and make the solution that every 1ml contains 60 μ g, promptly get reference substance solution; This product 0.5ml is measured in the preparation of need testing solution, precision, puts in the 50ml measuring bottle, adds 50% methanol and is diluted to scale, shakes up, and filters, and promptly gets need testing solution; Algoscopy, accurate respectively reference substance solution and each 10 μ l of need testing solution of drawing inject chromatograph of liquid, measure, that is and: the every 1ml of this product contains Radix Scutellariae in baicalin, must not be less than 5.8mg.
13,, it is characterized in that this method may further comprise the steps as the method for quality control of arbitrary described Chinese medicine composition composition spray among the claim 3-6:
Differentiate: A. gets this product 2ml, adds barium chloride test solution 1ml, promptly generates white precipitate; Separate, be deposited in the hydrochloric acid and do not dissolve;
B. get this product 10ml, put in the water-bath and steam to thick, add sulphuric acid 2ml, after the mixing, add methanol 8ml, ignition promptly generates the boundary zone green flame;
C. get this product 10ml, add 20～70 ℃ of petroleum ether 20ml, jolting is extracted gently, leaves standstill, and gets supernatant, volatilizes, and residue adds dehydrated alcohol 1ml makes dissolving, as need testing solution; Other gets Borneolum Syntheticum, Mentholum reference substance, adds dehydrated alcohol respectively and makes the solution that every 1ml contains 2mg, in contrast product solution; Test according to thin layer chromatography, draw each 2 μ l of above-mentioned three kinds of solution, put respectively in same be on the silica gel g thin-layer plate of adhesive with the sodium carboxymethyl cellulose, 20～70 ℃-ethyl acetate-benzene of petroleum ether that with the ratio is 7-10: 1-2: 1-3 is developing solvent, launch, take out, dry, spray is with the phosphomolybdic acid test solution, and it is clear to be heated to the speckle colour developing at 105 ℃; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the speckle of same color;
D. get this product 10ml, add strong ammonia solution 0.3ml, extract 1-3 time with the chloroform jolting, each 10ml, combined chloroform liquid, evaporate to dryness, residue add chloroform 1ml makes dissolving, as need testing solution; Other gets the matrine reference substance, and chlorination is copied into the solution that every 1ml contains 1mg, in contrast product solution; Test according to thin layer chromatography, draw need testing solution 2 μ l, reference substance solution 5 μ l, put respectively in same be on the silica gel g thin-layer plate of binding agent with the sodium carboxymethyl cellulose, ethyl acetate-methanol-the strong ammonia solution that with the ratio is 9-12: 0.8-1.5: 0.1-0.4 is developing solvent, launches, and takes out, dry, spray is with rare bismuth potassium iodide test solution; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the speckle of same color;
E. get this product 30ml, extract 1-3 time with 50～90 ℃ of petroleum ether joltings, each 15ml discards petroleum ether liquid, aqueous solution stirs with 2mol/L hydrochloric acid solution adjust pH to 2, and is centrifugal, filters, taking precipitate, oven dry grinds, and adds chloroform 30ml, hydrochloric acid 3ml, reflux 1-2 hour, put coldly, filter, divide and get chloroform solution, water 10ml washing discards water lotion, and chloroform solution adds anhydrous sodium sulfate and dewaters in right amount, evaporate to dryness, residue add dehydrated alcohol 1ml makes dissolving, as need testing solution; Extracting liquorice subacid reference substance adds dehydrated alcohol and makes the solution that every 1ml contains 2mg, in contrast product solution in addition; Test according to thin layer chromatography, draw need testing solution 3～5 μ l, reference substance solution 3 μ l, put respectively in same be on the silica gel g thin-layer plate of binding agent with the sodium carboxymethyl cellulose, be that 30～60 ℃-benzene-ethyl acetate of petroleum ether-glacial acetic acid of 9-12: 18-25: 8-12: 0.3-0.7 is developing solvent with the ratio, launch, take out, dry, spray is with the phosphomolybdic acid test solution, and it is clear to be heated to speckle colour developing at 105-115 ℃; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the speckle of same color;
Assay: according to high effective liquid chromatography for measuring, chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; The methanol-water-phosphoric acid that with the ratio is 45-55: 45-55: 0.1-0.4 is a mobile phase; The detection wavelength is 277nm; Theoretical cam curve is calculated by the baicalin peak should be not less than 3500; The preparation of reference substance solution, precision take by weighing at 50-70 ℃ of vacuum drying 3-5 hour baicalin reference substance an amount of, add methanol and make the solution that every 1ml contains 60 μ g, promptly get reference substance solution; This product 0.5ml is measured in the preparation of need testing solution, precision, puts in the 50ml measuring bottle, adds 45-60% methanol and is diluted to scale, shakes up, and filters, and promptly gets need testing solution; Algoscopy, accurate respectively reference substance solution and each 10 μ l of need testing solution of drawing inject chromatograph of liquid, measure, that is and: the every 1ml of this product contains Radix Scutellariae in baicalin, must not be less than 5.8-6.6mg.
14, the method for quality control of Chinese medicine composition composition spray as claimed in claim 13 is characterized in that this method may further comprise the steps:
Differentiate: A. gets this product 2ml, adds barium chloride test solution 1ml, promptly generates white precipitate; Separate, be deposited in the hydrochloric acid and do not dissolve;
B. get this product 10ml, put in the water-bath and steam to thick, add sulphuric acid 2ml, after the mixing, add methanol 8ml, ignition promptly generates the boundary zone green flame;
C. get this product 10ml, add 30～60 ℃ of petroleum ether 20ml, jolting is extracted gently, leaves standstill, and gets supernatant, volatilizes, and residue adds dehydrated alcohol 1ml makes dissolving, as need testing solution; Other gets Borneolum Syntheticum, Mentholum reference substance, adds dehydrated alcohol respectively and makes the solution that every 1ml contains 2mg, in contrast product solution; Test according to thin layer chromatography, draw each 2 μ l of above-mentioned three kinds of solution, put respectively in same be on the silica gel g thin-layer plate of adhesive with the sodium carboxymethyl cellulose, with ratio is that 30～60 ℃-ethyl acetate-benzene of petroleum ether of 9: 1: 2 is developing solvent, launch, take out, dry, spray is with the phosphomolybdic acid test solution, and it is clear to be heated to the speckle colour developing at 105 ℃; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the speckle of same color;
D. get this product 10ml, add strong ammonia solution 0.3ml, extract 2 times with the chloroform jolting, each 10ml, combined chloroform liquid, evaporate to dryness, residue add chloroform 1ml makes dissolving, as need testing solution; Other gets the matrine reference substance, and chlorination is copied into the solution that every 1ml contains 1mg, in contrast product solution; Test according to thin layer chromatography, draw need testing solution 2 μ l, reference substance solution 5 μ l, put respectively in same be on the silica gel g thin-layer plate of binding agent with the sodium carboxymethyl cellulose, with ratio is that ethyl acetate-methanol-strong ammonia solution of 10: 1: 0.2 is developing solvent, launches, and takes out, dry, spray is with rare bismuth potassium iodide test solution; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the speckle of same color;
E. get this product 30ml, extract 2 times with 60～90 ℃ of petroleum ether joltings, each 15ml discards petroleum ether liquid, aqueous solution stirs with 2mol/L hydrochloric acid solution adjust pH to 2, and is centrifugal, filters, taking precipitate, oven dry grinds, and adds chloroform 30ml, hydrochloric acid 3ml, reflux 1 hour is put coldly, filters, divide and get chloroform solution, water 10ml washing discards water lotion, and chloroform solution adds anhydrous sodium sulfate and dewaters in right amount, evaporate to dryness, residue add dehydrated alcohol 1ml makes dissolving, as need testing solution; Extracting liquorice subacid reference substance adds dehydrated alcohol and makes the solution that every 1ml contains 2mg, in contrast product solution in addition; Test according to thin layer chromatography, draw need testing solution 3～5 μ l, reference substance solution 3 μ l, put respectively in same be on the silica gel g thin-layer plate of binding agent with the sodium carboxymethyl cellulose, be 10: 20: 10 with ratio: 30～60 ℃-benzene-ethyl acetate of petroleum ether-glacial acetic acid of 0.5 is developing solvent, launches, take out, dry, spray is with the phosphomolybdic acid test solution, and it is clear to be heated to speckle colour developing at 105 ℃; In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the speckle of same color;
Assay: according to high effective liquid chromatography for measuring, chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; With ratio is that 50: 50: 0.2 methanol-water-phosphoric acid is a mobile phase; The detection wavelength is 277nm; Theoretical cam curve is calculated by the baicalin peak should be not less than 3500; The preparation of reference substance solution, precision take by weighing at 4 hours baicalin reference substance of 60 ℃ of vacuum dryings an amount of, add methanol and make the solution that every 1ml contains 60 μ g, promptly get reference substance solution; This product 0.5ml is measured in the preparation of need testing solution, precision, puts in the 50ml measuring bottle, adds 50% methanol and is diluted to scale, shakes up, and filters, and promptly gets need testing solution; Algoscopy, accurate respectively reference substance solution and each 10 μ l of need testing solution of drawing inject chromatograph of liquid, measure, that is and: the every 1ml of this product contains Radix Scutellariae in baicalin, must not be less than 5.8mg.
15, the application of Chinese medicine composition as claimed in claim 1 or 2 in preparation treatment oral cavity and throat wind-heat syndrome medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03137148 CN1233378C (en) | 2003-06-05 | 2003-06-05 | Chinese medicine composition for treating oral cavity and throat diseases and its preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03137148 CN1233378C (en) | 2003-06-05 | 2003-06-05 | Chinese medicine composition for treating oral cavity and throat diseases and its preparing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1457869A CN1457869A (en) | 2003-11-26 |
| CN1233378C true CN1233378C (en) | 2005-12-28 |
Family
ID=29430664
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03137148 Expired - Lifetime CN1233378C (en) | 2003-06-05 | 2003-06-05 | Chinese medicine composition for treating oral cavity and throat diseases and its preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1233378C (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1299748C (en) * | 2004-10-13 | 2007-02-14 | 谭玉杰 | Fat reducing regulating Qi supplement bag |
| CN101332269B (en) * | 2008-07-10 | 2011-09-07 | 江汉大学 | Traditional Chinese medicine propellant for treating pharyngitis and preparation method thereof |
| CN101396488B (en) * | 2008-10-29 | 2011-06-01 | 宗希阳 | Medicine for treating chronic faucitis |
| CN102038747B (en) * | 2009-10-16 | 2012-03-07 | 刘新义 | Compound electuary for treating faucitis |
| CN105288305A (en) * | 2015-11-30 | 2016-02-03 | 延欣虹 | Pharmaceutical composition for curing oral excessive inflammation and gingival pain and swelling and preparation method of pharmaceutical composition |
| CN107536947B (en) * | 2016-06-28 | 2021-02-02 | 桂林三金药业股份有限公司 | Application of traditional Chinese medicine composition in preparation of medicine for preventing and/or treating hand-foot-and-mouth disease |
| CN111289630A (en) * | 2018-12-07 | 2020-06-16 | 桂林三金药业股份有限公司 | Method for measuring content of menthol in traditional Chinese medicine composition by gas chromatography |
| CN110354247B (en) * | 2019-08-12 | 2020-06-26 | 马晟利 | Haematococin compound preparation for treating oral candidiasis and preparation method thereof |
| CN110927321B (en) * | 2019-11-06 | 2022-07-01 | 桂林三金药业股份有限公司 | Quality detection method of throat soothing spray |
-
2003
- 2003-06-05 CN CN 03137148 patent/CN1233378C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CN1457869A (en) | 2003-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100457139C (en) | Method for preparing a Shuanhuanglian injection and the component detecting method | |
| CN1233378C (en) | Chinese medicine composition for treating oral cavity and throat diseases and its preparing method | |
| CN101234159A (en) | Pharmaceutical combination with synergistic reaction | |
| CN1872106A (en) | Application of wild basil circle leaves in treating disease of virulence cold | |
| CN100349597C (en) | Chinese medicinal preparation for treating virus myocaraitis, its preparation method and quality control method | |
| CN110755386A (en) | Application of thesium Chinese granules in preparation of medicine for treating hyperpyrexia caused by pathogenic bacteria infection | |
| CN102920964B (en) | Traditional Chinese medicine preparation for curing cough | |
| CN101716300B (en) | Cough relief traditional Chinese medicine compound preparation and preparation method thereof | |
| CN102389496B (en) | Chinese medical composition for treating hepatitis and preparation method thereof | |
| CN1273493C (en) | Angelica polysaccharide and its preparation and use | |
| CN1292778C (en) | Chinese medicine composition for stopping itching and its preparing method | |
| CN1476855A (en) | A kind of traditional Chinese medicine composition and preparation method thereof | |
| CN1264529C (en) | Freeze-dried 'Shenqifuzheng' powder for injection and its preparing process | |
| CN101332216B (en) | Xingsiang Tuerfeng total phenolic acid extract and preparation method thereof | |
| CN105477361B (en) | A kind of Chinese medicine composition preparation method that treating gastritis and preparation | |
| CN101084979B (en) | Medicinal preparation for cancer auxiliary treatment and its preparation method | |
| CN1323682C (en) | Chinese medicine preparation of infectious external contraction high fever and production thereof | |
| CN1237998C (en) | Effervescence tablet for treating children's cough and asthma and its preparation | |
| CN101574381A (en) | Extractive of effective part of chloranthus glaber and preparation method thereof | |
| CN1090485C (en) | Psoriasis resisting capsule and its preparation | |
| CN111588742A (en) | Application of myrrh sesquiterpene extract in preparation of chronic obstructive pulmonary disease medicine | |
| CN1887324A (en) | Chinese composition and its prepn process and quality control method | |
| CN1205971C (en) | Naolejing granular preparation | |
| CN1803178A (en) | Traditional Chinese medicine composition and its preparation method and quality control method | |
| CN115715784B (en) | Traditional Chinese medicine composition for treating chronic pharyngitis, application and pharmaceutical preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term |
Granted publication date: 20051228 |
|
| CX01 | Expiry of patent term |